ATEC vs. IART, ATRC, OFIX, OSUR, TCMD, GMED, NARI, LMAT, TNDM, and NVCR
Should you be buying Alphatec stock or one of its competitors? The main competitors of Alphatec include Integra LifeSciences (IART), AtriCure (ATRC), Orthofix Medical (OFIX), OraSure Technologies (OSUR), Tactile Systems Technology (TCMD), Globus Medical (GMED), Inari Medical (NARI), LeMaitre Vascular (LMAT), Tandem Diabetes Care (TNDM), and NovoCure (NVCR). These companies are all part of the "surgical & medical instruments" industry.
Alphatec (NASDAQ:ATEC) and Integra LifeSciences (NASDAQ:IART) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership.
Alphatec has a beta of 1.55, meaning that its share price is 55% more volatile than the S&P 500. Comparatively, Integra LifeSciences has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500.
Integra LifeSciences has a net margin of 4.39% compared to Alphatec's net margin of -38.70%. Integra LifeSciences' return on equity of 15.19% beat Alphatec's return on equity.
66.4% of Alphatec shares are held by institutional investors. Comparatively, 84.8% of Integra LifeSciences shares are held by institutional investors. 29.1% of Alphatec shares are held by insiders. Comparatively, 3.1% of Integra LifeSciences shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Integra LifeSciences received 123 more outperform votes than Alphatec when rated by MarketBeat users. Likewise, 58.39% of users gave Integra LifeSciences an outperform vote while only 56.52% of users gave Alphatec an outperform vote.
Integra LifeSciences has higher revenue and earnings than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Integra LifeSciences, indicating that it is currently the more affordable of the two stocks.
In the previous week, Alphatec had 1 more articles in the media than Integra LifeSciences. MarketBeat recorded 7 mentions for Alphatec and 6 mentions for Integra LifeSciences. Alphatec's average media sentiment score of 0.58 beat Integra LifeSciences' score of -0.16 indicating that Alphatec is being referred to more favorably in the media.
Alphatec currently has a consensus target price of $23.63, indicating a potential upside of 85.00%. Integra LifeSciences has a consensus target price of $44.89, indicating a potential upside of 56.24%. Given Alphatec's stronger consensus rating and higher probable upside, research analysts plainly believe Alphatec is more favorable than Integra LifeSciences.
Summary
Integra LifeSciences beats Alphatec on 10 of the 18 factors compared between the two stocks.
Get Alphatec News Delivered to You Automatically
Sign up to receive the latest news and ratings for ATEC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ATEC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Alphatec Competitors List
Related Companies and Tools
